Covidien says tissue reinforcement product linked to three patient deaths
11 February 2012
Bloomberg News (1/17, Connolly) reports that Boulder, CO-based Covidien Plc announced that "a tissue reinforcement product used in medical staplers has been connected with three patient deaths after use in thoracic surgery."
| Previous: Scientists devise method of re-sensitizing certain bacteria to antibiotics | Study Bolsters Prior Research On Adding Oxaliplatin To Colon Cancer Chemotherapy Next: |
|---|
Comments